Pluristem Therapeutics CEO Zami Aberman's 2009 pay falls 24% to $580K
Pluristem Therapeutics reports 2009 executive compensation
By ExecPay News
Published: November 23, 2009
Pluristem Therapeutics reported fiscal year 2009 executive compensation information on November 23, 2009.
In 2009, two executives at Pluristem Therapeutics received on average a compensation package of $450K, a 27% decrease compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Zami Aberman, Chief Executive Officer, received $580K in total, which decreased by 24% compared to 2008. 57% of Aberman's compensation, or $332K, was in stock awards. Aberman also received $248K in salary.
Yaky Yanay, Chief Financial Officer, received a compensation package of $319K, which decreased by 31% compared to previous year. 50% of the compensation package, or $159K, was in stock awards.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on November 23, 2009.